Safety Study of Topical Human FGF-1 for Wound Healing

Clinical trial NCT00916292 · UNKNOWN

Trial details

NCT number: NCT00916292
Sponsor: Phage Pharmaceuticals, Inc.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetic Foot Ulcers

Start date: 2012-11-01
Primary completion: 2013-09-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.